Receptor News and Research

RSS

Early radionuclide therapy delays progression in metastatic prostate cancer

Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators at several other institutions worldwide.

6 Aug 2026

Ferroptosis-based therapy shows promise for advanced prostate cancer treatment

A recent review explores the rapidly expanding field of ferroptosis-based therapy for prostate cancer, presenting ferroptosis as a promising strategy to overcome resistance in advanced and castration-resistant prostate cancer (CRPC).

6 Aug 2026

Stanford researcher receives NIH grant to develop molecular imaging agent for localizing lung tumors during surgery

Lung cancer remains the leading cause of cancer-related deaths, and surgery is a critical treatment option for early-stage disease.

6 Aug 2026

Researchers uncover mechanism linking skin inflammation to body-wide allergies

Our bodies experience allergic reactions when the immune system mistakenly overreacts to harmless substances, known as allergens, such as pollen, dust, or certain foods.

6 Aug 2026

Risk-adapted frameworks reshape pediatric neuroblastoma care

Neuroblastoma is the most common solid tumor outside the brain in children younger than five years old and accounts for about 15% of pediatric cancer deaths.

6 Aug 2026

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today.

5 Aug 2026

Long-acting HIV prevention tools could help close the gap before a vaccine arrives

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, vertical transmission programs, and voluntary medical male circumcision. Gene editing and multispecific antibodies may expand future options, but safety, cost, access, adherence, and implementation barriers remain.

5 Aug 2026

New insights highlight Megalin's expanding role in disease management

A comprehensive new analysis is shining a spotlight on Megalin, a powerful and highly versatile receptor that plays a central role in maintaining cellular balance, organ function, and overall human health.

5 Aug 2026

Discovery may help develop new treatments for immunosuppressed skin cancer patients

Researchers at The University of Texas MD Anderson Cancer Center have discovered that immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively.

5 Aug 2026

Inherited Neandertal gene variant increases muscle mass in modern humans

Neandertals were generally more strongly built than most people living today. Their bones show signs of large muscles, and they had characteristic features such as prominent brow ridges and relatively short tooth roots.

5 Aug 2026

Versatile receptor protein plays critical role in regulating tissue repair

A comprehensive new review highlights the expanding importance of Lgr6, a member of the G protein-coupled receptor family, as a critical regulator of tissue homeostasis, injury repair, and disease development across multiple organ systems.

5 Aug 2026

Mouse study shows how liraglutide briefly rewires gut bacterial communities

Researchers treated male high-fat-fed mice with liraglutide for 14 days, then tracked fecal bacterial communities after a 7-day washout using 16S rRNA sequencing. Liraglutide shifted the microbiome toward Lactobacillus- and Leptogranulimonas-related taxa while reducing several fermentative taxa, but most changes moved back toward baseline after treatment stopped.

4 Aug 2026

$GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes$

GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes

New research by UCLA Health found GLP-1 medications may reduce the risk of serious fractures for adults with type 2 diabetes.

4 Aug 2026

Malaria infection causes permanent damage to the spleen immune cells

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or "scavenger cells," to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne.

4 Aug 2026

Cryo-EM study reveals dynamic structure of human norovirus

Human norovirus is the leading cause of acute gastroenteritis worldwide and is estimated to infect 600–700 million people each year.

4 Aug 2026

Researchers suggest a potential therapeutic strategy for muscle loss associated with obesity

Obesity has been linked to skeletal muscle loss and deterioration. While M2 macrophages may play a role in regulating muscle function, the underlying mechanisms remain poorly understood.

4 Aug 2026

Food may taste different on GLP-1 drugs, but taste may not be the reason

The review suggests that patient-reported “taste changes” during GLP-1RA treatment may reflect reduced food enjoyment and motivation rather than consistent impairment of basic taste. The authors propose a sensory-liking-wanting framework while emphasizing that current human evidence remains heterogeneous and largely indirect.

4 Aug 2026

Receptor News and Research

Early radionuclide therapy delays progression in metastatic prostate cancer

Ferroptosis-based therapy shows promise for advanced prostate cancer treatment

Stanford researcher receives NIH grant to develop molecular imaging agent for localizing lung tumors during surgery

Researchers uncover mechanism linking skin inflammation to body-wide allergies

Risk-adapted frameworks reshape pediatric neuroblastoma care

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Long-acting HIV prevention tools could help close the gap before a vaccine arrives

New insights highlight Megalin's expanding role in disease management

Discovery may help develop new treatments for immunosuppressed skin cancer patients

Inherited Neandertal gene variant increases muscle mass in modern humans

Versatile receptor protein plays critical role in regulating tissue repair

Mouse study shows how liraglutide briefly rewires gut bacterial communities

GLP-1 therapy may help reduce fracture risk among adults with type 2 diabetes

Malaria infection causes permanent damage to the spleen immune cells

Cryo-EM study reveals dynamic structure of human norovirus

Researchers suggest a potential therapeutic strategy for muscle loss associated with obesity

Food may taste different on GLP-1 drugs, but taste may not be the reason

Newly-discovered protein acts as off switch for human immune cells

RNA-based therapeutic strategy targets brain pathway behind cancer-associated cachexia

Blocking xenophagocytosis improves donor cell survival and interspecies organ generation

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News